Most recent papers with the keyword Lymphoma | Read by QxMD
... or combined modality treatment consisting of a brief chemotherapy with 2 cycles of ABVD (doxorubicin, bleomycin, vinblastine, ... and second-line therapy of Hodgkin lymphoma. Preliminary data show that brentuximab vedotin alone is not adequate therapy for ... "primary prevention of cancer" (heart or cardiac or cardio*) AND arrest -"American Heart Association" ... During the past 10 years improvements in survival have been achieved with the implementation of anti-CD20 immunotherapy and ...https://www.readbyqxmd.com/keyword/958
Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era |...
We characterized trends in treatment modalities for MIBC from 2004... ... Introduction Muscle-invasive bladder cancer (MIBC) is an aggressive disease for which treatment strategies are continuously ... Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy ... Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era. ...https://rd.springer.com/article/10.1007/s00345-018-2371-y
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models. - PubMed - NCBI
Cancer Immunol Res. 2015 Feb;3(2):136-48. doi: 10.1158/2326-6066.CIR-14-0036. Epub 2014 Nov 4. Research Support, N.I.H., ... Combined Modality Therapy. *Drug Evaluation, Preclinical/methods. *Immune Tolerance/drug effects. *Immunotherapy/methods* ... A major barrier for cancer immunotherapy is the presence of suppressive cell populations in patients with cancer, such as ... Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.. Shen L1, Sundstedt A2, ...https://www.ncbi.nlm.nih.gov/pubmed/25370534
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer - Tabular View - ClinicalTrials.gov
ECP has been distinguished from other forms of anti-cancer immunotherapy by both its efficacy and safety, but its evolution has ... No treatment for lung cancer (chemotherapy, radiation therapy, biomodifiers) for 4 weeks prior to entry. ... Combined Modality Treatment for Non-Small Cell Lung Cancer. Official Title ICMJE Phase 1 Toxicity/Feasibility Study: Combined ... Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer. The safety and scientific validity of this study is ...https://clinicaltrials.gov/ct2/show/record/NCT00265603?show_desc=Y
Combining radiation and immunotherapy | OncologyPRO
Multi-modality and multi-drug cancer therapy. Topics. Personalised Medicine. Translational Research. Cancer Immunology and ... Cancer Immunology and Immunotherapy. Get information on recent advances in cancer immunology & immunotherapy and keep up with ... Anti-Cancer Agents and Biological Therapy. Find the essential information, user-friendly publications and resources presenting ... Cancer in Medical Journals. Collection of links to the latest cancer related articles in top medical journals: Annals of ...http://oncologypro.esmo.org/Topics/Cancer-Immunology-and-Immunotherapy/Combining-radiation-and-immunotherapy
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy | Cancer Research
... combining radiotherapy and immunotherapy can be done following a variety of different modalities. Determining the exact ... T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res 2008;14:4883-90. ... Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013;105:256-65. ... Combining radiation and immunotherapy: a new systemic. Cancer Immunol Res 2014;2:831-8. ...http://cancerres.aacrjournals.org/content/76/17/4931.long
Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-epileptic Drug Treatment in Children With Refractory Seizures
Neoadjuvant Therapy. Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, ... Therapy with two or more separate preparations given for a combined effect. ... hyperthermia, etc.) that precedes a necessary second modality of treatment.. Drug Therapy, Combination ... Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. ...https://www.bioportfolio.com/resources/trial/65227/Trial-to-Assess-Vagus-Nerve-Stimulation-Therapy-vs-Anti-epileptic-Drug-Treatment.html
Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy - University of Salford...
An important developing area for clinical evaluation is the testing of combined conventional and immunotherapeutic modalities ... RESULTS/CONCLUSION: Many cancer vaccines and antibody-directed therapies have been tested in early phase clinical trials and ... Elkord, E, Hawkins, R and Stern, P 2008, 'Immunotherapy for gastrointestinal cancer: current status and strategies for ... cancer vaccines and targeted drugs and highlight the scientific rationale of using immunotherapy for targeting GI cancers, in ...http://usir.salford.ac.uk/18279/
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved...
Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunol Immunother 2008; 57: 1523-1529.. *CrossRef ... Combining vaccines with conventional therapies for cancer. Update Cancer Ther 2007; 2: 33-39.. *CrossRef , ... Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004; 4: 11-22.. *CrossRef , ... Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy, Human ...http://onlinelibrary.wiley.com/doi/10.1002/jgm.2605/full
The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent
... as well as novel therapies, with a specific focus on molecular targeted agents and immune therapies. ... and health care professionals working in breast cancer research and management. The journal publishes original research ... International Journal of Breast Cancer is a peer-reviewed, Open Access journal that provides a forum for scientists, clinicians ... O. Balogun and S. C. Formenti, "Combining radiotherapy and immunotherapy," Cancer Treatment and Research, no. 9783319532332, pp ...https://www.hindawi.com/journals/ijbc/2018/4786819/
Hybrid Vaccine Demonstrates Potential To Prevent Breast Cancer Recurrence
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has ... from vaccines and antibodies to combining these modalities and improving response rates." The findings will be presented at ... "Adjuvant therapies currently used for breast cancer are taken ongoing. Otherwise, their effect to block cancer development is ... "This is an exciting time for immunotherapy as we transfer knowledge from the lab to clinic. There's a renewed enthusiasm to ...https://www.medicalnewstoday.com/releases/245571.php
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer - Full Text View -...
Stage IV or IIIB (disease that is not eligible for combined modality chemotherapy and radiation) ... Prior chemotherapy, immunotherapy or biologic therapy for metastatic NSCLC. *Up to one prior adjuvant or neoadjuvant ... Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer. This study has been ... carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. ...https://clinicaltrials.gov/ct2/show/NCT00088556
Cancer | definition of cancer by Medical dictionary
... cancer explanation free. What is cancer? Meaning of cancer medical term. What does cancer mean? ... Looking for online definition of cancer in the Medical Dictionary? ... Surgery, chemotherapy, immunotherapy, hormone therapy, radiation therapy, and combined-modality therapies often are effective ... Regional cancer, Residual cancer, Scar cancer, Second cancer, Skin cancer, Small cell lung cancer, Solid cancer, Solid cancer, ...http://medical-dictionary.thefreedictionary.com/Cancer
Eradicating HIV-1 infection: seeking to clear a persistent pathogen - Review
Synergy has often been described as a combined effect that is greater than the sum of the effect of two separate modalities. ... Combination cancer chemotherapy and immunotherapy have only recently been successfully used after many years of intense ... do host-targeted anti-latency therapies affect such adjunctive therapies?. Clearing persistently infected cells. The induction ... This effort should be linked to studies of the disruption of latency, as the modalities are likely to be combined. Therefore, ...http://www.natap.org/2014/HIV/103114_02.htm
An immunotherapy is any therapy that trains a patient's own immune system to detect and destroy cancer cells. Many of our ... making UMGCCC one of the region's leaders in this growing area of cancer treatment research.,/p, ... p,UMGCCC gives patients access to many different forms of immunotherapy. ... physicians are principal investigators in immunotherapy clinical trials, ...https://www.umms.org/umgccc/cancer-services/cancer-care/research-clinical-trials/clinical-trials/cancer-immunotherapy
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer
Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a hig... ... radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of ... CONFORMAL RADIOTHERAPY that combines several intensity-modulated beams to provide improved dose homogeneity and highly ... Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer. 2014-08-27 03:19:43 , BioPortfolio ...https://www.bioportfolio.com/resources/trial/73273/Radiation-Therapy-in-Treating-Patients-Receiving-Hormone-Therapy-for-Prostate-Cancer.html
CRC | definition of CRC by Medical dictionary
Surgery, chemotherapy, immunotherapy, hormone therapy, radiation therapy, and combined-modality therapies often are effective ... prostate cancer. See: prostate cancer. scirrhous cancer. Hard cancer.. skin cancer. A broad term that includes basal cell ... epithelial cancer of the ovary. See: ovarian cancer. esophageal cancer. See: esophageal cancer. fallopian tube cancer. A ... cancer of the pancreas. Pancreatic cancer.. pancreatic cancer. Carcinoma of the pancreas. The American Cancer Society estimated ...https://medical-dictionary.thefreedictionary.com/CRC
Gordon Li, MD | Stanford Medicine Profiles
Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence ... The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers Patel, M. A., Kim, J. E., Ruzevick ... Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side ... Therapeutic immune approaches include cytokine therapy, passive immunotherapy, and active immunotherapy. Cytokine therapy ...https://med.stanford.edu/profiles/gordon-li
FDA Review in Journal for ImmunoTherapy of Cancer Offers New Insights into Cancer Immunotherapy Product Development & Clinical ...
ImmunoTherapy,of,Cancer,Offers,New,Insights,into,Cancer,Immunotherapy,Product,Development,&,Clinical,Evaluation,biological, ... appears in an extensive new review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. ... A picture of what the FDA is looking for in cancer immunotherapy product development ... As mechanisms of tumor immune escape have become better defined, approaches that combine two or more modalities to overcome ...http://www.bio-medicine.org/biology-technology-1/FDA-Review-in-Journal-for-ImmunoTherapy-of-Cancer-Offers-New-Insights-into-Cancer-Immunotherapy-Product-Development--26amp-3B-Clinical-Evaluation-26356-1/
Genitourinary Malignancies Branch | Center for Cancer Research - National Cancer Institute
He has pioneered the effort to combine experimental therapies such as angiogenesis and immunotherapy with chemotherapy, ... androgen blockade, radiotherapy and other more traditional modalities. His recent studies combining immunotherapy with more ... He has pioneered the effort to combine experimental therapies such as angiogenesis and immunotherapy with chemotherapy, ... and prostate cancer. In particular, she is working to develop new bladder cancer therapies that use targeted agents including ...https://ccr.cancer.gov/Genitourinary-Malignancies-Branch?qt-lab_branch_patient_tabs=2
Regulation of cancer by therapeutic vaccination and dietary bio-modulation involving organ-specific mitochondria on...
Cancer therapy should aim to prevent recurrent disease. Surgery and toxic treatments remove only symptoms associated with ... Article Regulation of cancer by therapeutic vaccination and dietary bio-modulation involving organ-specific mitochondria. ... Our findings indicate that combined immunological and biological modality called 'bio-immunotherapy' is an effective approach ... Keywords: biological cancer therapy, autologous cancer vaccine, mitochondrial gene regulation, cancer aetiology, metabolic ...https://www.environmental-expert.com/articles/regulation-of-cancer-by-therapeutic-vaccination-and-dietary-bio-modulation-involving-organ-specific--80684
William L. Dahut, M.D. | Center for Cancer Research - National Cancer Institute
He has pioneered the effort to combine experimental therapies such as angiogenesis and immunotherapy with chemotherapy, ... androgen blockade, radiotherapy and other more traditional modalities. His recent studies combining immunotherapy with more ... Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. ... The research program in prostate cancer has been focused on attempting to develop hypothesis-driven novel therapies for each ...https://ccr.cancer.gov/genitourinary-malignancies-branch/william-l-dahut
How Immunotherapy Is Revolutionizing Cancer Care - The ASCO Post
The idea of combining different modalities in different molecules is very exciting, and hopefully, it will be very fruitful for ... Today, immunotherapy for the treatment of a variety of cancers is rapidly evolving from therapies that nonspecifically ... It is also logical to start using combination immunotherapies in the treatment of cancer. For example, CAR-T-cell therapy ... Potential of Immunotherapy. How is immunotherapy already changing clinical practice in the treatment of a variety of cancers, ...http://www.ascopost.com/issues/may-25-2016/how-immunotherapy-is-revolutionizing-cancer-care/
Sir Gustav Nossal, immunologist | Australian Academy of Science
... a cancer therapy modality will come forward.. Everything we've learnt about cancer in these last 50 years of very frontal study ... by immunotherapy? The jury isn't yet in on this one, I think, but I would look more to a future which combines cellular therapy ... The big question is whether this will include the common cancers. Most of the triumphs in cancer therapy in the recent past ... The continuing fight against cancer. We're facing an extremely interesting future in regard to the cancer problem too, because ...https://www.science.org.au/learning/general-audience/history/interviews-australian-scientists/sir-gustav-nossal-immunologist-2
Combining Molecular-Driven Approach and Immunotherapy to Improve Treatment for Patients With Inflammatory Breast Cancer - The...
Treatment for inflammatory breast cancer requires multimodality therapy, with chemotherapy, mastectomy, and radiation therapy ... "So what can we do to improve on this modality of treatment, and what can we add? First of all, we can certainly look at the ... Combining Molecular-Driven Approach and Immunotherapy to Improve Treatment for Patients With Inflammatory Breast Cancer. By ... Combining Molecular-Driven Approach and Immunotherapy to Improve Treatment for Patients With Inflammatory Breast Cancer ...http://www.ascopost.com/issues/december-10-2015/combining-molecular-driven-approach-and-immunotherapy-to-improve-treatment-for-patients-with-inflammatory-breast-cancer/